A
Anthony Lucci
Researcher at University of Texas MD Anderson Cancer Center
Publications - 289
Citations - 15687
Anthony Lucci is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 61, co-authored 258 publications receiving 12908 citations. Previous affiliations of Anthony Lucci include Baylor College of Medicine & St. John's University.
Papers
More filters
Journal ArticleDOI
Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.
Sonia A. Melo,Hikaru Sugimoto,Hikaru Sugimoto,Joyce T. O’Connell,Noritoshi Kato,Alberto Villanueva,August Vidal,Le Qiu,Edward Vitkin,Lev T. Perelman,Carlos A. Melo,Anthony Lucci,Cristina Ivan,George A. Calin,Raghu Kalluri,Raghu Kalluri +15 more
TL;DR: It is reported that breast cancer associated exosomes contain microRNAs (miRNAs) associated with the RISC-Loading Complex (RLC) and display cell-independent capacity to process precursor micro RNAs (pre-miRNas) into mature miRNAs.
Journal ArticleDOI
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink,Sangeetha M. Reddy,Jianjun Gao,Shaojun Zhang,Rafet Basar,Rohit Thakur,Keren Yizhak,Moshe Sade-Feldman,Moshe Sade-Feldman,Jorge Blando,Guangchun Han,Vancheswaran Gopalakrishnan,Yuanxin Xi,Hao Zhao,Rodabe N. Amaria,Hussein Abdul-Hassan Tawbi,Alex P. Cogdill,Wenbin Liu,Valerie S. LeBleu,Fernanda G. Kugeratski,Sapna Pradyuman Patel,Michael A. Davies,Patrick Hwu,Jeffrey E. Lee,Jeffrey E. Gershenwald,Anthony Lucci,Reetakshi Arora,Scott E. Woodman,Emily Z. Keung,Pierre Olivier Gaudreau,Alexandre Reuben,Christine N. Spencer,Elizabeth M. Burton,Lauren E. Haydu,Alexander J. Lazar,Roberta Zapassodi,Courtney W. Hudgens,Deborah A. Ledesma,SuFey Ong,Michael Bailey,Sarah Warren,Disha Rao,Oscar Krijgsman,Elisa A. Rozeman,Daniel S. Peeper,Christian U. Blank,Ton N. Schumacher,Lisa H. Butterfield,Monika A. Zelazowska,Kevin M. McBride,Raghu Kalluri,James P. Allison,Florent Petitprez,Florent Petitprez,Wolf H. Fridman,Wolf H. Fridman,Catherine Sautès-Fridman,Catherine Sautès-Fridman,Nir Hacohen,Nir Hacohen,Katayoun Rezvani,Padmanee Sharma,Michael T. Tetzlaff,Linghua Wang,Jennifer A. Wargo +64 more
TL;DR: B cell markers were the most differentially expressed genes in the tumours of responders versus non-responders and insights are provided into the potential role of B cells and tertiary lymphoid structures in the response to ICB treatment, with implications for the development of biomarkers and therapeutic targets.
Journal ArticleDOI
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011
Anthony Lucci,Linda M. McCall,Peter D. Beitsch,Patrick W. Whitworth,Douglas S. Reintgen,Peter W. Blumencranz,A. Marilyn Leitch,Sukumal Saha,Kelly K. Hunt,Armando E. Giuliano +9 more
TL;DR: Complications associated with SLN dissection (SLND) plus ALND, versus SLND alone resulted in more wound infections, axillary seromas, and paresthesias thanSLND alone, and the use of SLNDalone resulted in fewer complications.
Journal ArticleDOI
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria,Sangeetha M. Reddy,Hussein Abdul-Hassan Tawbi,Michael A. Davies,Merrick I. Ross,Isabella C. Glitza,Janice N. Cormier,Carol M. Lewis,Wen-Jen Hwu,Ehab Y. Hanna,Adi Diab,Michael K. Wong,Richard E. Royal,Neil D. Gross,Randal S. Weber,Stephen Y. Lai,Richard A. Ehlers,Jorge Blando,Denái R. Milton,Scott E. Woodman,Robin Kageyama,Daniel K. Wells,Patrick Hwu,Sapna Pradyuman Patel,Anthony Lucci,Amy C. Hessel,Jeffrey E. Lee,Jeffrey E. Gershenwald,Lauren Simpson,Elizabeth M. Burton,Liberty Posada,Lauren E. Haydu,Linghua Wang,Shaojun Zhang,Alexander J. Lazar,Courtney W. Hudgens,Vancheswaran Gopalakrishnan,Alexandre Reuben,Miles C. Andrews,Christine N. Spencer,Victor G. Prieto,Padmanee Sharma,James P. Allison,Michael T. Tetzlaff,Jennifer A. Wargo +44 more
TL;DR: The feasibility of neoadjuvant immune checkpoint blockade in melanoma is described and the need for additional studies to optimize treatment regimens and to validate putative biomarkers is emphasized.
Journal ArticleDOI
Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial
Lee G. Wilke,Linda M. McCall,Katherine E. Posther,Pat Whitworth,Douglas S. Reintgen,A. Marilyn Leitch,Sheryl G. A. Gabram,Anthony Lucci,Charles E. Cox,Kelly K. Hunt,James E. Herndon,Armando E. Giuliano +11 more
TL;DR: This study provides a prospective assessment of the sentinel lymph node biopsy procedure, as performed by a wide range of surgeons, demonstrating a low complication rate.